CNS-话题@MedSci

#CNS#

70篇内容 | 1143人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2180561, encodeId=58bb218056195, content=<a href='/topic/show?id=4b8349356f' target=_blank style='color:#2F92EE;'>#CNS#</a> <a href='/topic/show?id=c5795004ece' target=_blank style='color:#2F92EE;'>#弥漫性大B细胞淋巴瘤#</a>, objectTitle=【Exp Hematol Oncol】高危DLBCL的CNS预防新进展, objectType=article, longId=808766, objectId=3804808e6657, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/young-people-on-medical-staff-meeting-ZFY96R4.jpg, objectUrl=/article/show_article.do?id=3804808e6657, replyNumber=0, likeNumber=17, createdTime=2024-01-10, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=3804808e6657, moduleTitle=【Exp Hematol Oncol】高危DLBCL的CNS预防新进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3804808e6657)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1914278, encodeId=cb0919142e830, content=<a href='/topic/show?id=4b8349356f' target=_blank style='color:#2F92EE;'>#CNS#</a>, objectTitle=Lancet Oncol：阿特珠单抗+Cobimetinib+Vemurafenib治疗CNS转移的黑色素瘤, objectType=article, longId=735293, objectId=8390e3529363, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8390e3529363, replyNumber=0, likeNumber=59, createdTime=2022-10-22, rootId=0, userName=lg.zhao, userId=c737344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8390e3529363, moduleTitle=Lancet Oncol：阿特珠单抗+Cobimetinib+Vemurafenib治疗CNS转移的黑色素瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8390e3529363)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1914277, encodeId=b13819142e73a, content=<a href='/topic/show?id=4b8349356f' target=_blank style='color:#2F92EE;'>#CNS#</a>, objectTitle=Ther Adv Med Oncol：转移性乳腺癌患者中仅中枢神经系统（CNS）转移的临床病理特征和临床预后, objectType=article, longId=300125, objectId=1817300125e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1817300125e9, replyNumber=0, likeNumber=40, createdTime=2022-08-29, rootId=0, userName=lg.zhao, userId=c737344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1817300125e9, moduleTitle=Ther Adv Med Oncol：转移性乳腺癌患者中仅中枢神经系统（CNS）转移的临床病理特征和临床预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1817300125e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1914276, encodeId=412a19142e660, content=<a href='/topic/show?id=4b8349356f' target=_blank style='color:#2F92EE;'>#CNS#</a>, objectTitle=Stroke：TMAO水平与缺血性卒中复发相关（CNSR-III研究）, objectType=article, longId=291837, objectId=4df929183ebb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4df929183ebb, replyNumber=0, likeNumber=52, createdTime=2021-12-28, rootId=0, userName=lg.zhao, userId=c737344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4df929183ebb, moduleTitle=Stroke：TMAO水平与缺血性卒中复发相关（CNSR-III研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4df929183ebb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1914271, encodeId=3bd119142e169, content=<a href='/topic/show?id=4b8349356f' target=_blank style='color:#2F92EE;'>#CNS#</a>, objectTitle=Blood：免疫抑制下发生的EBV相关原发性CNS淋巴瘤是一种独特的疾病, objectType=article, longId=208732, objectId=1c39208e32e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c39208e32e7, replyNumber=0, likeNumber=49, createdTime=2021-08-11, rootId=0, userName=lg.zhao, userId=c737344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c39208e32e7, moduleTitle=Blood：免疫抑制下发生的EBV相关原发性CNS淋巴瘤是一种独特的疾病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c39208e32e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1914273, encodeId=136d19142e35d, content=<a href='/topic/show?id=4b8349356f' target=_blank style='color:#2F92EE;'>#CNS#</a>, objectTitle=Blood Cancer J：大剂量甲氨蝶呤可有效预防DLBCL患者孤立性CNS复发, objectType=article, longId=216228, objectId=5cf7216228e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5cf7216228e4, replyNumber=0, likeNumber=50, createdTime=2022-05-20, rootId=0, userName=lg.zhao, userId=c737344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5cf7216228e4, moduleTitle=Blood Cancer J：大剂量甲氨蝶呤可有效预防DLBCL患者孤立性CNS复发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5cf7216228e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1914275, encodeId=644b19142e5df, content=<a href='/topic/show?id=4b8349356f' target=_blank style='color:#2F92EE;'>#CNS#</a>, objectTitle=J Thorac Oncol：CNS渗透性TKI单药vs TKI+放疗治疗EGFR/ALK阳性NSCLC脑转移患者的疗效 , objectType=article, longId=217043, objectId=644421e04318, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=644421e04318, replyNumber=0, likeNumber=24, createdTime=2022-06-23, rootId=0, userName=lg.zhao, userId=c737344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=644421e04318, moduleTitle=J Thorac Oncol：CNS渗透性TKI单药vs TKI+放疗治疗EGFR/ALK阳性NSCLC脑转移患者的疗效 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=644421e04318)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1914274, encodeId=8cc319142e459, content=<a href='/topic/show?id=4b8349356f' target=_blank style='color:#2F92EE;'>#CNS#</a>, objectTitle=J Thorac Onco：奥希替尼单药抗NSCLC患者未放疗过的CNS转移灶的疗效, objectType=article, longId=216361, objectId=29db21636143, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=29db21636143, replyNumber=0, likeNumber=50, createdTime=2021-10-15, rootId=0, userName=lg.zhao, userId=c737344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=29db21636143, moduleTitle=J Thorac Onco：奥希替尼单药抗NSCLC患者未放疗过的CNS转移灶的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=29db21636143)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1914270, encodeId=bd1f19142e05f, content=<a href='/topic/show?id=4b8349356f' target=_blank style='color:#2F92EE;'>#CNS#</a>, objectTitle=Lancet Haematol：MATRix–RICE方案联合自体HSCT治疗继发CNS浸润的弥漫大B细胞淋巴瘤的疗效显著, objectType=article, longId=206905, objectId=e68520690580, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e68520690580, replyNumber=0, likeNumber=48, createdTime=2021-10-08, rootId=0, userName=lg.zhao, userId=c737344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e68520690580, moduleTitle=Lancet Haematol：MATRix–RICE方案联合自体HSCT治疗继发CNS浸润的弥漫大B细胞淋巴瘤的疗效显著, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e68520690580)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1914272, encodeId=022d19142e261, content=<a href='/topic/show?id=4b8349356f' target=_blank style='color:#2F92EE;'>#CNS#</a>, objectTitle=你与CNS,缺一个从PET-CT到空间定位分析的升级, objectType=article, longId=209363, objectId=e33a20936364, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e33a20936364, replyNumber=0, likeNumber=46, createdTime=2021-10-31, rootId=0, userName=lg.zhao, userId=c737344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e33a20936364, moduleTitle=你与CNS,缺一个从PET-CT到空间定位分析的升级, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e33a20936364)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1914264, encodeId=069119142647b, content=<a href='/topic/show?id=4b8349356f' target=_blank style='color:#2F92EE;'>#CNS#</a>, objectTitle=JAMA Neurol：警惕TNF抑制剂治疗导致的炎症性CNS事件风险, objectType=article, longId=194779, objectId=4c3d194e797a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4c3d194e797a, replyNumber=0, likeNumber=47, createdTime=2021-01-02, rootId=0, userName=lg.zhao, userId=c737344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4c3d194e797a, moduleTitle=JAMA Neurol：警惕TNF抑制剂治疗导致的炎症性CNS事件风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4c3d194e797a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1914269, encodeId=26d2191426912, content=<a href='/topic/show?id=4b8349356f' target=_blank style='color:#2F92EE;'>#CNS#</a>, objectTitle=Acta Neuropathologica: CNS副神经节瘤的分子特征确定马尾副神经节瘤是一种独特的肿瘤实体, objectType=article, longId=200862, objectId=93ab2008626c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=93ab2008626c, replyNumber=0, likeNumber=53, createdTime=2021-02-11, rootId=0, userName=lg.zhao, userId=c737344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=93ab2008626c, moduleTitle=Acta Neuropathologica: CNS副神经节瘤的分子特征确定马尾副神经节瘤是一种独特的肿瘤实体, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=93ab2008626c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1914268, encodeId=37d71914268e3, content=<a href='/topic/show?id=4b8349356f' target=_blank style='color:#2F92EE;'>#CNS#</a>, objectTitle=Nat Commun：CNS肿瘤免疫微环境分析揭示抗肿瘤免疫相关性, objectType=article, longId=200495, objectId=17e9200495fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=17e9200495fd, replyNumber=0, likeNumber=37, createdTime=2021-05-10, rootId=0, userName=lg.zhao, userId=c737344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=17e9200495fd, moduleTitle=Nat Commun：CNS肿瘤免疫微环境分析揭示抗肿瘤免疫相关性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=17e9200495fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1914263, encodeId=15b41914263c1, content=<a href='/topic/show?id=4b8349356f' target=_blank style='color:#2F92EE;'>#CNS#</a>, objectTitle=Neurology：表现为反复脑出血的原发性 CNS 血管炎, objectType=article, longId=193262, objectId=b100193262ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b100193262ed, replyNumber=0, likeNumber=52, createdTime=2020-05-04, rootId=0, userName=lg.zhao, userId=c737344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b100193262ed, moduleTitle=Neurology：表现为反复脑出血的原发性 CNS 血管炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b100193262ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1914265, encodeId=453719142656e, content=<a href='/topic/show?id=4b8349356f' target=_blank style='color:#2F92EE;'>#CNS#</a>, objectTitle=CNS第一期刊之争，Nature又有子刊上线了, objectType=article, longId=196250, objectId=9bf91962502a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9bf91962502a, replyNumber=0, likeNumber=45, createdTime=2021-04-30, rootId=0, userName=lg.zhao, userId=c737344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9bf91962502a, moduleTitle=CNS第一期刊之争，Nature又有子刊上线了, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9bf91962502a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1914266, encodeId=b88c19142665f, content=<a href='/topic/show?id=4b8349356f' target=_blank style='color:#2F92EE;'>#CNS#</a>, objectTitle=Bood：结外自然杀伤/T细胞淋巴瘤患者CNS复发的预测和预防, objectType=article, longId=196933, objectId=99aa19693328, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=99aa19693328, replyNumber=0, likeNumber=46, createdTime=2020-09-20, rootId=0, userName=lg.zhao, userId=c737344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=99aa19693328, moduleTitle=Bood：结外自然杀伤/T细胞淋巴瘤患者CNS复发的预测和预防, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=99aa19693328)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1914267, encodeId=a506191426eac, content=<a href='/topic/show?id=4b8349356f' target=_blank style='color:#2F92EE;'>#CNS#</a>, objectTitle=盘点：用时最短！中国学者突破100篇CNS生命科学领域成果；高福/饶子和/秦川都大于4篇；上海科技大学及山东农业大学表现出色, objectType=article, longId=198223, objectId=f15019822356, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f15019822356, replyNumber=0, likeNumber=44, createdTime=2020-11-11, rootId=0, userName=lg.zhao, userId=c737344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f15019822356, moduleTitle=盘点：用时最短！中国学者突破100篇CNS生命科学领域成果；高福/饶子和/秦川都大于4篇；上海科技大学及山东农业大学表现出色, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f15019822356)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1914262, encodeId=fcbb191426261, content=<a href='/topic/show?id=4b8349356f' target=_blank style='color:#2F92EE;'>#CNS#</a>, objectTitle=2019 WCLC ∣奥希替尼160mg为EGFR T790M突变阳性伴CNS转移NSCLC患者带来显著获益, objectType=article, longId=179499, objectId=164d1e9499e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=164d1e9499e1, replyNumber=0, likeNumber=35, createdTime=2020-02-01, rootId=0, userName=lg.zhao, userId=c737344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=164d1e9499e1, moduleTitle=2019 WCLC ∣奥希替尼160mg为EGFR T790M突变阳性伴CNS转移NSCLC患者带来显著获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=164d1e9499e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1914261, encodeId=6fa219142610c, content=<a href='/topic/show?id=4b8349356f' target=_blank style='color:#2F92EE;'>#CNS#</a>, objectTitle=【CNS学院·大咖说】刘安文教授： EGFR突变阳性晚期NSCLC脑转移防治策略, objectType=article, longId=178512, objectId=7fb11e8512e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7fb11e8512e3, replyNumber=0, likeNumber=53, createdTime=2020-02-22, rootId=0, userName=lg.zhao, userId=c737344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7fb11e8512e3, moduleTitle=【CNS学院·大咖说】刘安文教授： EGFR突变阳性晚期NSCLC脑转移防治策略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7fb11e8512e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1914257, encodeId=c577191425e48, content=<a href='/topic/show?id=4b8349356f' target=_blank style='color:#2F92EE;'>#CNS#</a>, objectTitle=CNS Drugs：SSRIs在改善脑卒中后功能结局上有何作用？, objectType=article, longId=152035, objectId=fa181520355c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fa181520355c, replyNumber=0, likeNumber=36, createdTime=2019-09-01, rootId=0, userName=lg.zhao, userId=c737344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fa181520355c, moduleTitle=CNS Drugs：SSRIs在改善脑卒中后功能结局上有何作用？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fa181520355c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

CNS

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#CNS# #弥漫性大B细胞淋巴瘤#

【Exp Hematol Oncol】高危DLBCL的CNS预防新进展

2024-01-10发表于陕西省

lg.zhao (审核中...)

前往app查看评论内容

#CNS#

Lancet Oncol：阿特珠单抗+Cobimetinib+Vemurafenib治疗CNS转移的黑色素瘤

2022-10-22

lg.zhao (审核中...)

前往app查看评论内容

#CNS#

Ther Adv Med Oncol：转移性乳腺癌患者中仅中枢神经系统（CNS）转移的临床病理特征和临床预后

2022-08-29

lg.zhao (审核中...)

前往app查看评论内容

#CNS#

Stroke：TMAO水平与缺血性卒中复发相关（CNSR-III研究）

2021-12-28

lg.zhao (审核中...)

前往app查看评论内容

#CNS#

Blood：免疫抑制下发生的EBV相关原发性CNS淋巴瘤是一种独特的疾病

2021-08-11

lg.zhao (审核中...)

前往app查看评论内容

#CNS#

Blood Cancer J：大剂量甲氨蝶呤可有效预防DLBCL患者孤立性CNS复发

2022-05-20

lg.zhao (审核中...)

前往app查看评论内容

#CNS#

J Thorac Oncol：CNS渗透性TKI单药vs TKI+放疗治疗EGFR/ALK阳性NSCLC脑转移患者的疗效

2022-06-23

lg.zhao (审核中...)

前往app查看评论内容

#CNS#

J Thorac Onco：奥希替尼单药抗NSCLC患者未放疗过的CNS转移灶的疗效

2021-10-15

lg.zhao (审核中...)

前往app查看评论内容

#CNS#

Lancet Haematol：MATRix–RICE方案联合自体HSCT治疗继发CNS浸润的弥漫大B细胞淋巴瘤的疗效显著

2021-10-08

lg.zhao (审核中...)

前往app查看评论内容

#CNS#

你与CNS,缺一个从PET-CT到空间定位分析的升级

2021-10-31

lg.zhao (审核中...)

前往app查看评论内容

#CNS#

JAMA Neurol：警惕TNF抑制剂治疗导致的炎症性CNS事件风险

2021-01-02

lg.zhao (审核中...)

前往app查看评论内容

#CNS#

Acta Neuropathologica: CNS副神经节瘤的分子特征确定马尾副神经节瘤是一种独特的肿瘤实体

2021-02-11

lg.zhao (审核中...)

前往app查看评论内容

#CNS#

Nat Commun：CNS肿瘤免疫微环境分析揭示抗肿瘤免疫相关性

2021-05-10

lg.zhao (审核中...)

前往app查看评论内容

#CNS#

Neurology：表现为反复脑出血的原发性 CNS 血管炎

2020-05-04

lg.zhao (审核中...)

前往app查看评论内容

#CNS#

CNS第一期刊之争，Nature又有子刊上线了

2021-04-30

lg.zhao (审核中...)

前往app查看评论内容

#CNS#

Bood：结外自然杀伤/T细胞淋巴瘤患者CNS复发的预测和预防

2020-09-20

lg.zhao (审核中...)

前往app查看评论内容

#CNS#

盘点：用时最短！中国学者突破100篇CNS生命科学领域成果；高福/饶子和/秦川都大于4篇；上海科技大学及山东农业大学表现出色

2020-11-11

lg.zhao (审核中...)

前往app查看评论内容

#CNS#

2019 WCLC ∣奥希替尼160mg为EGFR T790M突变阳性伴CNS转移NSCLC患者带来显著获益

2020-02-01

lg.zhao (审核中...)

前往app查看评论内容

#CNS#

【CNS学院·大咖说】刘安文教授： EGFR突变阳性晚期NSCLC脑转移防治策略

2020-02-22

lg.zhao (审核中...)

前往app查看评论内容

#CNS#

CNS Drugs：SSRIs在改善脑卒中后功能结局上有何作用？

2019-09-01

科室
- - 订阅+
  - 更多科室
工具
服务